Regadenoson
Product Images NDC 72611-874

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 72611-874). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almaject, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson-spl-carton (Regadenoson Spl Carton)

Packaging label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) by Almaject, Inc., NDC 72611-874-10. The label indicates 5 mL single-dose vials in a 10-vial package. It is a pharmacologic stress agent for intravenous use only, for diagnostic purposes. The label includes storage instructions and manufacturing details.*

FDA Label Image

Regadenoson-spl-structure (Regadenoson Spl Structure)

Chemical structure diagram of Regadenoson. The image shows the molecular arrangement including a sugar moiety and heterocyclic rings consistent with the chemical structure of the active ingredient Regadenoson.*

FDA Label Image

Regadenoson-spl-vial (Regadenoson Spl Vial)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) sterile solution for intravenous use as a pharmacologic stress agent. The 5 mL single-dose vial label includes storage instructions, lot and expiration placeholders, manufacturer Almaject, Inc. in Morristown, NJ, and regulatory information with an NDC number 72611-874-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.